- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NDG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose(Post Translational Modification)
- 26 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: R.44, Y.487
Ligand excluded by PLIPSO4.3: 2 residues within 4Å:- Chain A: E.254, R.257
Ligand excluded by PLIPSO4.4: 3 residues within 4Å:- Chain A: Q.169, R.170, P.428
Ligand excluded by PLIPSO4.5: 2 residues within 4Å:- Chain A: R.44, S.45
Ligand excluded by PLIPSO4.6: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: T.63, G.64, Q.440
- Chain B: K.473
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain A: R.329, L.330
- Chain C: K.321, R.329
Ligand excluded by PLIPSO4.13: 2 residues within 4Å:- Chain B: R.44, Y.487
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain B: E.254, R.257
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: Q.169, R.170, P.428
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: R.44, S.45
Ligand excluded by PLIPSO4.17: 6 residues within 4Å:- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain A: K.473
- Chain B: T.63, G.64, Q.440
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: R.329, L.330
- Chain D: K.321, R.329
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain C: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain C: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.26: 7 residues within 4Å:- Chain B: S.242
- Chain C: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain C: R.44, S.45
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain C: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain D: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain D: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.34: 7 residues within 4Å:- Chain A: S.242
- Chain D: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.35: 2 residues within 4Å:- Chain D: R.44, S.45
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain D: R.44, S.465, Y.487
Ligand excluded by PLIP- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.10: 7 residues within 4Å:- Chain A: R.2, D.24, S.25, F.26, R.48, M.49, Y.418
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.24, A:D.24
GOL.11: 2 residues within 4Å:- Chain A: V.394, R.395
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:V.394
GOL.21: 7 residues within 4Å:- Chain B: R.2, D.24, S.25, F.26, R.48, M.49, Y.418
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.24
GOL.22: 2 residues within 4Å:- Chain B: V.394, R.395
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:V.394
GOL.30: 10 residues within 4Å:- Chain C: D.127, F.128, W.179, N.234, E.235, F.246, Y.313, E.340, W.381, N.396
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:W.179, C:N.234, C:E.235, C:W.381, C:N.396
GOL.38: 10 residues within 4Å:- Chain D: D.127, F.128, W.179, N.234, E.235, F.246, Y.313, E.340, W.381, N.396
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:W.179, D:N.234, D:E.235, D:W.381, D:N.396
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, R.R. et al., Crystal Structure of Glucocerebrosidase Containing the N370S Mutation, Implications for Chaperon Therapy. To be Published
- Release Date
- 2010-10-27
- Peptides
- Glucosylceramidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NDG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose(Post Translational Modification)
- 26 x SO4: SULFATE ION(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, R.R. et al., Crystal Structure of Glucocerebrosidase Containing the N370S Mutation, Implications for Chaperon Therapy. To be Published
- Release Date
- 2010-10-27
- Peptides
- Glucosylceramidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
BD
B